{
    "url_original": "https://www.wsj.com/articles/moderna-drops-pursuit-of-u-s-patent-for-key-component-of-covid-19-vaccine-11639782753?mod=business_lead_pos2",
    "url": "moderna-drops-pursuit-of-u-s-patent-for-key-component-of-covid-19-vaccine-11639782753",
    "title": "Moderna Drops Pursuit of U.S. Patent for Key Component of Covid-19 Vaccine",
    "sub_head": "The company had been in a dispute with the National Institutes of Health over who invented key component of the widely used vaccine",
    "category_1": "Business",
    "category_2": "Health Care",
    "image_1_url": "https://images.wsj.net/im-454852?width=860&height=573",
    "image_1": "im-454852.jpg",
    "time": "2021-12-17 18:12:00",
    "body": "Moderna Inc.  has abandoned its application for a U.S. patent covering its Covid-19 vaccine that has been the subject of a heated dispute with the National Institutes of Health over the invention of a key component of the shot.<br />The Cambridge, Mass., company said Friday it dropped the patent application “to allow more time for discussions with the NIH” aimed at an amicable resolution."
}